fda
3 records
FDA Drug Recall: Timolol-Latanoprost (0.5/0.005%) ophthalmic drops, Compounded, 5 mL bottle, Impr
2022-11-23
Class II — Subpotent Drug: The batches contain less than 90% of the labeled amount of latanoprost.
View Source
FDA Drug Recall: Timolol- Dorzolamide- Latanoprost P-F (0.5/2.0/0.005%) ophthalmic drops, package
2019-08-07
Class II — Subpotent Drug
View Source
FDA Drug Recall: Timolol-Latanoprost P-F (0.5/0.005%) ophthalmic drops, packaged in 5mL bottles,
2019-08-07
Class II — Subpotent Drug
View Source
nppes
1 records
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.